cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Cancer treatment reports

• Publication date

  1979-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 498158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.

  1978cited by this paper
• Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.

  1978cited by this paper
• Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.

  1977cited by this paper
• CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.

  1977cited by this paper
• Cis-diamminedichloroplatinum (II). A new anticancer drug.

  1977cited by this paper
• Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.

  1977cited by this paper
• Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).

  1976cited by this paper
• Phase II evaluation of cis-diamminedichloroplatinum(II) in lung cancer.

  1976cited by this paper
• Combination chemotherapy with adriamycin and cis‐diamminedichloroplatinum in patients with neoplastic diseases

  1976cited by this paper
• Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.

  1975cited by this paper
• Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.

  1975cited by this paper
• Review of the current clinical status of platinum coordination complexes in cancer chemotherapy.

  1975cited by this paper

• A phase I study with Satraplatin and simultaneous chest radiation for non-small cell lung cancer

  2012cites this paper
• DEFINITIVE MANAGEMENT OF INOPERABLE NON–SMALL CELL LUNG CANCER

  2008cites this paper
• The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer, vol. 30.

  2007cites this paper
• Platinums in lung cancer: sufficient or necessary?

  2005cites this paper
• Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay

  2004cites this paper
• Changes in the stria vascularis of the guinea pig due to cis-platinum

  2004cites this paper
• Chemotherapy of advanced non-small cell lung cancer

  2004cites this paper
• Development of cis-platinum-induced hearing loss in guinea pigs

  2004cites this paper
• Basic treatment considerations: chemotherapy.

  2004cites this paper
• A brief historical review of the development of chemotherapy for the treatment of advanced non-small cell lung cancer: why we should look beyond platinum.

  1999cites this paper
• A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis.

  1998cites this paper
• A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

  1993cites this paper
• Pharmacokinetic Evaluation of (Glycolato‐O, O′) diammine Platinum(II) in Lung Lymph in Sheep

  1993cites this paper
• Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.

  1991cites this paper
• Chemotherapy for stage IV non-small cell lung cancer.

  1990cites this paper
• A phase II trial of high‐dose cytarabine and cisplatin in previously untreated non‐small cell carcinoma of the lung. A piedmont oncology association study

  1990cites this paper
• Chemosensitivity test using subrenal capsule assays

  1990cites this paper
• Combination chemotherapy for advanced adenocarcinoma of the lung

  1988cites this paper
• Non-small cell lung cancer.

  1988cites this paper
• The Role of Combination Cyclophosphamide, Doxorubicin and Cisplatin (Cap) Chemotherapy in Advanced Non-Small-Cell Lung Cancer

  1987cites this paper
• Non-small cell lung cancer.

  1987cites this paper
• シスプラチン単剤にて腫瘍細胞の完全消失が認められた肺癌 (大細胞癌) の一例

  1986cites this paper
• Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study.

  1985cites this paper
• Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.

  1985cites this paper
• Update in cancer chemotherapy, Part III: Lung cancer, Part 1.

  1985cites this paper
• Camp chemotherapy for metastatic non‐oat cell bronchogenic carcinoma. A 7‐year experience (1975–1981) with 160 patients

  1985cites this paper
• New frontiers in the treatment of lung cancer.

  1985cites this paper
• Ifosfamide--pharmacology, safety and therapeutic potential.

  1985cites this paper
• A Prospective Randomized Trial of Combination Vindesine and Cisplatin Versus Single‐agent Vindesine in Advanced Non‐small Cell Lung Cancer

  1985cites this paper
• Die Chemotherapie der nicht-kleinzelligen Bronchuskarzinome

  1985cites this paper
• Phase II study of cis-diamminedichloroplatinum in patients with non-small cell lung cancer.

  1985cites this paper
• Treatment of the rabbit V-2 carcinoma with intralesional cisplatin.

  1985cites this paper
• A phase II study of 4'-epi-doxorubicin plus cis-platinum in advanced solid tumors.

  1984cites this paper
• Chemotherapy of advanced non-small cell lung cancer. A review.

  1984cites this paper
• Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.

  1984cites this paper
• Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.

  1984cites this paper
• Phase II trial of cyclophosphamide and cis‐platinum for non‐small cell bronchogenic carcinoma

  1984cites this paper
• cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial.

  1984cites this paper
• Randomized phase III comparison of three doxorubicin-based chemotherapy regimens in advanced non-small cell lung cancer: a Southeastern Cancer Study Group trial.

  1984cites this paper
• [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].

  1984cites this paper
• Prospective evaluation of thymosin fraction V immunotherapy in patients with non‐small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapy

  1984cites this paper
• [Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study].

  1983cites this paper
• The systemic chemotherapy of hepatic metastases.

  1983cites this paper
• Chemotherapy of metastatic non-small cell bronchogenic carcinoma.

  1983cites this paper
• Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.

  1982cites this paper
• Organo-platinum complexes as antitumor agents (review).

  1982cites this paper
• A review of etoposide in patients with non-small-cell lung cancer (NSCLC).

  1982cites this paper
• Chemotherapy and radiation therapy for non-small cell lung carcinoma.

  1982cites this paper
• Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.

  1982cites this paper
• Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.

  1982cites this paper
• Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

  1981cites this paper
• Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.

  1981cites this paper
• Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.

  1981cites this paper
• Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.

  1981cites this paper
• Platinum‐based combination chemotherapy in non‐small cell lung carcinoma

  1981cites this paper
• Lung cancer. Chemotherapy as curative treatment.

  1981cites this paper
• Commentary: current status of chemotherapy for non-small cell lung cancer.

  1981cites this paper
• Chemotherapy of non-small cell lung cancer: Clinical trials at the Memorial Sloan-Kettering Cancer Center

  1981cites this paper
• Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.

  1979cites this paper